Hennion & Walsh Asset Management’s AstraZeneca AZN Stock Holding History

Hennion & Walsh Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,093	Closed	-$283K	–	776
2022 Q4	$283K	Buy	+2,093	New	+$262K	0.02%	647
2022 Q3	–	Sell	-1,932	Closed	-$255K	–	767
2022 Q2	$255K	Sell	1,932 -340	-15%	-$44.6K	0.02%	668
2022 Q1	$301K	Buy	2,272 +147	+7%	+$17.6K	0.02%	655
2021 Q4	$247K	Sell	2,125 -575	-21%	-$67.7K	0.01%	677
2021 Q3	$324K	Sell	2,700 -6,808	-72%	-$792K	0.02%	618
2021 Q2	$1.14M	Sell	9,508 -482	-5%	-$52.9K	0.06%	335
2021 Q1	$993K	Buy	+9,990	New	+$1M	0.06%	356

Other funds holding AZN

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Jennison Associates

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return